{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:53:06Z","timestamp":1793145186529,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Autologous T-cell therapies show limited efficacy in chronic lymphocytic leukemia (CLL), where acquired immune dysfunction prevails. In CLL, disturbed mitochondrial metabolism has been linked to defective T-cell activation and proliferation. Recent research suggests that lipid metabolism regulates mitochondrial function and differentiation in T cells, yet its role in CLL remains unexplored. This comprehensive study compares T-cell lipid metabolism in CLL patients and healthy donors, revealing critical dependence on exogenous cholesterol for human T-cell expansion following TCR-mediated activation. Using multi-omics and functional assays, we found that T cells present in viably frozen samples of patients with CLL (CLL T cells) showed impaired adaptation to cholesterol deprivation and inadequate upregulation of key lipid metabolism transcription factors. CLL T cells exhibited altered lipid storage, with increased triacylglycerols and decreased cholesterol, and inefficient fatty acid oxidation (FAO). Functional consequences of reduced FAO in T cells were studied using samples from patients with inherent FAO disorders. Reduced FAO was associated with lower T-cell activation but did not affect proliferation. This implicates low cholesterol levels as a primary factor limiting T-cell proliferation in CLL. CLL T cells displayed fewer and less clustered lipid rafts, potentially explaining the impaired immune synapse formation observed in these patients. Our findings highlight significant disruptions in lipid metabolism as drivers of functional deficiencies in CLL T cells, underscoring the pivotal role of cholesterol in T-cell proliferation. This study suggests that modulating cholesterol metabolism could enhance T-cell function in CLL, presenting novel immunotherapeutic approaches to improve outcome in this challenging disease.<\/jats:p>","DOI":"10.1038\/s41423-025-01262-1","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T20:02:31Z","timestamp":1741032151000},"page":"485-500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia"],"prefix":"10.1038","volume":"22","author":[{"given":"Chaja F.","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0509-315X","authenticated-orcid":false,"given":"Fleur S.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9885-456X","authenticated-orcid":false,"given":"Elena","family":"Camerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaspard","family":"Cretenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Rietveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bauke V.","family":"Schomakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4916-2866","authenticated-orcid":false,"given":"Michel","family":"van Weeghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne G. S.","family":"Verberk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7852-2891","authenticated-orcid":false,"given":"Jan","family":"Van den Bossche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Langeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Kleijwegt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0561-6640","authenticated-orcid":false,"given":"Eric","family":"Eldering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6935-7532","authenticated-orcid":false,"given":"Noam","family":"Zelcer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3190-1891","authenticated-orcid":false,"given":"Arnon P.","family":"Kater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2431-6133","authenticated-orcid":false,"given":"Helga","family":"Simon-Molas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"1262_CR1","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S1470-2045(23)00452-7","volume":"24","author":"CU Niemann","year":"2023","unstructured":"Niemann CU, Munir T, Moreno C, Owen C, Follows GA, Benjamini O, et al. Fixed-duration ibrutinib\u2013venetoclax versus chlorambucil\u2013obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2023;24:1423\u201333.","journal-title":"Lancet Oncol."},{"key":"1262_CR2","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1182\/bloodadvances.2021005083","volume":"5","author":"TE Lew","year":"2021","unstructured":"Lew TE, Lin VS, Cliff ER, Blombery P, Thompson ER, Handunnetti SM, et al. Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition. Blood Adv. 2021;5:4054\u20138.","journal-title":"Blood Adv."},{"key":"1262_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/ejh.14076","volume":"112","author":"AN Khan","year":"2024","unstructured":"Khan AN, Asija S, Pendhari J, Purwar R. CAR-T cell therapy in hematological malignancies: Where are we now and where are we heading for? Eur J Haematol. 2024;112:6\u201318.","journal-title":"Eur J Haematol."},{"key":"1262_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","volume":"602","author":"JJ Melenhorst","year":"2022","unstructured":"Melenhorst JJ, Chen GM, Wang M, Porter DL, Chen C, Collins MA, et al. Decade-long leukaemia remissions with persistence of CD4+ CAR T cells. Nature. 2022;602:503\u20139.","journal-title":"Nature."},{"issue":"Suppl 1","key":"1262_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1182\/blood-2023-179529","volume":"142","author":"T Siddiqi","year":"2023","unstructured":"Siddiqi T, Maloney DG, Kenderian SS, Brander DM, Dorritie K, Soumerai J. et al. Lisocabtagene Maraleucel (liso-cel) in R\/R CLL\/SLL: 24-month median follow-up of TRANSCEND CLL 004. Blood. 2023;142(Suppl 1):330.","journal-title":"Blood"},{"key":"1262_CR6","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3324\/haematol.2020.267914","volume":"106","author":"FS Peters","year":"2021","unstructured":"Peters FS, Strefford JC, Eldering E, Kater AP. T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective. Haematologica. 2021;106:1234\u201343.","journal-title":"Haematologica."},{"key":"1262_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41375-023-01817-z","volume":"37","author":"AWJ Martens","year":"2023","unstructured":"Martens AWJ, Kavazovi\u0107 I, Krapi\u0107 M, Pack SM, Arens R, Jongejan A, et al. Chronic lymphocytic leukemia presence impairs antigen-specific CD8+ T-cell responses through epigenetic reprogramming towards short-lived effectors. Leukemia. 2023;37:606\u201316.","journal-title":"Leukemia."},{"key":"1262_CR8","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1182\/bloodadvances.2022007034","volume":"6","author":"JAC van Bruggen","year":"2022","unstructured":"van Bruggen JAC, van der Windt GJW, Hoogendoorn M, Dubois J, Kater AP, Peters FS. Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells. Blood Adv. 2022;6:4185\u201395.","journal-title":"Blood Adv."},{"key":"1262_CR9","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3109\/10428194.2012.673224","volume":"53","author":"SH Tonino","year":"2012","unstructured":"Tonino SH, van de Berg PJ, Yong SL, Ten Berge IJ, Kersten MJ, van Lier RAW, et al. Expansion of effector T cells associated with decreased PD-1 expression in patients with indolent B cell lymphomas and chronic lymphocytic leukemia. Leuk Lymphoma. 2012;53:1785\u201394.","journal-title":"Leuk Lymphoma."},{"key":"1262_CR10","first-page":"2427","volume":"118","author":"AG Ramsay","year":"2008","unstructured":"Ramsay AG, Johnson AJ, Lee AM, Gorg\u00fcn G, Le Dieu R, Blum W, et al. Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J Clin Investig. 2008;118:2427\u201337.","journal-title":"J Clin Investig."},{"key":"1262_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1182\/blood.2018885863","volume":"134","author":"JAC van Bruggen","year":"2019","unstructured":"van Bruggen JAC, Martens AWJ, Fraietta JA, Hofland T, Tonino SH, Eldering E, et al. Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy. Blood. 2019;134:44\u201358.","journal-title":"Blood."},{"key":"1262_CR12","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1182\/blood-2012-09-457531","volume":"121","author":"JC Riches","year":"2013","unstructured":"Riches JC, Davies JK, McClanahan F, Fatah R, Iqbal S, Agrawal S, et al. T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production. Blood. 2013;121:1612\u201321.","journal-title":"Blood."},{"key":"1262_CR13","doi-asserted-by":"crossref","unstructured":"van Bruggen JAC, Peters FS, Mes MJ, Rietveld JM, Cerretani E, Cretenet G, et al. T-cell dysfunction in CLL is mediated through expression of SIGLEC-10 ligands CD24 and CD52 on CLL cells. Blood Adv. 2024;8:4633\u201346.","DOI":"10.1182\/bloodadvances.2023011934"},{"key":"1262_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping NE, Menk AV, Moreci RS, Whetstone RD, Dadey RE, Watkins SC, et al. The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction. Immunity. 2016;45:374\u201388.","journal-title":"Immunity."},{"key":"1262_CR15","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","volume":"162","author":"PC Ho","year":"2015","unstructured":"Ho PC, Bihuniak JD, Macintyre AN, Staron M, Liu X, Amezquita R, et al. Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses. Cell. 2015;162:1217\u201328.","journal-title":"Cell."},{"key":"1262_CR16","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1084\/jem.20151159","volume":"212","author":"MD Buck","year":"2015","unstructured":"Buck MD, O\u2019Sullivan D, Pearce EL. T cell metabolism drives immunity. J Exp Med. 2015;212:1345\u201360.","journal-title":"J Exp Med."},{"key":"1262_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.smim.2016.10.009","volume":"28","author":"L Almeida","year":"2016","unstructured":"Almeida L, Lochner M, Berod L, Sparwasser T. Metabolic pathways in T cell activation and lineage differentiation. Semin Immunol. 2016;28:514\u201324.","journal-title":"Semin Immunol."},{"key":"1262_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41590-023-01733-5","volume":"25","author":"D Wilfahrt","year":"2024","unstructured":"Wilfahrt D, Delgoffe GM. Metabolic waypoints during T cell differentiation. Nat Immunol. 2024;25:206\u201317.","journal-title":"Nat Immunol."},{"key":"1262_CR19","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.4049\/jimmunol.180.7.4476","volume":"180","author":"SR Jacobs","year":"2008","unstructured":"Jacobs SR, Herman CE, Maciver NJ, Wofford JA, Wieman HL, Hammen JJ. et al. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol. 2008;180:4476\u201386.","journal-title":"J Immunol"},{"key":"1262_CR20","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ni.2556","volume":"14","author":"LV Sinclair","year":"2013","unstructured":"Sinclair LV, Rolf J, Emslie E, Shi YB, Taylor PM, Cantrell DA. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat Immunol. 2013;14:500\u20138.","journal-title":"Nat Immunol."},{"key":"1262_CR21","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","volume":"21","author":"K DePeaux","year":"2021","unstructured":"DePeaux K, Delgoffe GM. Metabolic barriers to cancer immunotherapy. Nat Rev Immunol. 2021;21:785\u201397.","journal-title":"Nat Rev Immunol."},{"key":"1262_CR22","doi-asserted-by":"publisher","first-page":"eabq3016","DOI":"10.1126\/sciimmunol.abq3016","volume":"8","author":"JJ Peng","year":"2023","unstructured":"Peng JJ, Wang L, Li Z, Ku CL, Ho PC. Metabolic challenges and interventions in CAR T cell therapy. Sci Immunol. 2023;8:eabq3016.","journal-title":"Sci Immunol."},{"key":"1262_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","volume":"20","author":"JA Olzmann","year":"2019","unstructured":"Olzmann JA, Carvalho P. Dynamics and functions of lipid droplets. Nat Rev Mol Cell Biol. 2019;20:137\u201355.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"1262_CR24","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3389\/fimmu.2017.01949","volume":"8","author":"D Howie","year":"2017","unstructured":"Howie D, Ten Bokum A, Necula AS, Cobbold SP, Waldmann H. The role of lipid metabolism in T lymphocyte differentiation and survival. Front Immunol. 2017;8:1949.","journal-title":"Front Immunol."},{"key":"1262_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08097","volume":"460","author":"EL Pearce","year":"2009","unstructured":"Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, Wang LS, et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature. 2009;460:103\u20137.","journal-title":"Nature."},{"key":"1262_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.immuni.2014.06.005","volume":"41","author":"D O\u2019Sullivan","year":"2014","unstructured":"O\u2019Sullivan D, van der Windt GJW, Huang SCC, Curtis JD, Chang CH, Buck MD, et al. Memory CD8+ T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity. 2014;41:75\u201388.","journal-title":"Immunity."},{"key":"1262_CR27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000527581","volume":"109","author":"Z Chen","year":"2023","unstructured":"Chen Z, Cretenet G, Carnazzo V, Simon-Molas H, Kater AP, van der Windt GJW, et al. Electron transport chain and mTOR inhibition synergistically decrease CD40 signaling and counteract venetoclax resistance in chronic lymphocytic leukemia. Haematologica. 2023;109:151\u201362.","journal-title":"Haematologica."},{"key":"1262_CR28","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/sj.leu.2403865","volume":"19","author":"Y Vasconcelos","year":"2005","unstructured":"Vasconcelos Y, De Vos J, Vallat L, R\u00e8me T, Lalanne AI, Wanherdrick K, et al. Gene expression profiling of chronic lymphocytic leukemia can discriminate cases with stable disease and mutated Ig genes from those with progressive disease and unmutated Ig genes. Leukemia. 2005;19:2002\u20135.","journal-title":"Leukemia."},{"key":"1262_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.leukres.2009.07.032","volume":"34","author":"M Mansouri","year":"2010","unstructured":"Mansouri M, Sevov M, Fahlgren E, Tobin G, Jondal M, Osorio L, et al. Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity. Leuk Res. 2010;34:301\u20136.","journal-title":"Leuk Res."},{"key":"1262_CR30","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00277-023-05590-y","volume":"103","author":"B Pan","year":"2024","unstructured":"Pan B, Xu Z, Du K, Gao R, Zhang J, Yin H, et al. Investigation of fatty acid metabolism in chronic lymphocytic leukemia to guide clinical outcome and therapy. Ann Hematol. 2024;103:1241\u201354.","journal-title":"Ann Hematol."},{"key":"1262_CR31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1182\/blood.2021011597","volume":"139","author":"CR Funk","year":"2022","unstructured":"Funk CR, Wang S, Chen KZ, Waller A, Sharma A, Edgar CL, et al. PI3K\u03b4\/\u03b3 inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity. Blood. 2022;139:523\u201337.","journal-title":"Blood."},{"key":"1262_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1182\/blood.2021013895","volume":"139","author":"FS Peters","year":"2022","unstructured":"Peters FS, Kater AP. Increasing CART cell engine performance in CLL. Blood. 2022;139:473\u20134.","journal-title":"Blood."},{"key":"1262_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85455-4","volume":"11","author":"NM Held","year":"2021","unstructured":"Held NM, Buijink MR, Elfrink HL, Kooijman S, Janssens GE, Luyf ACM, et al. Aging selectively dampens oscillation of lipid abundance in white and brown adipose tissue. Sci Rep. 2021;11:5932.","journal-title":"Sci Rep."},{"key":"1262_CR34","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2024)."},{"key":"1262_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 2011;12:323.","journal-title":"BMC Bioinform."},{"key":"1262_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol."},{"key":"1262_CR37","doi-asserted-by":"crossref","unstructured":"Ndoj K, Meurs A, Papaioannou D, Bjune K, Zelcer N. The low-density lipoprotein receptor: emerging post-transcriptional regulatory mechanisms. Atherosclerosis. 2025; 401. [cited 2025] Available from: https:\/\/www.atherosclerosis-journal.com\/article\/S0021-9150(24)01512-0\/fulltext.","DOI":"10.1016\/j.atherosclerosis.2024.119082"},{"key":"1262_CR38","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1074\/jbc.TM118.004165","volume":"294","author":"SR Pfeffer","year":"2019","unstructured":"Pfeffer SR. NPC intracellular cholesterol transporter 1 (NPC1)-mediated cholesterol export from lysosomes. J Biol Chem. 2019;294:1706\u20139.","journal-title":"J Biol Chem."},{"key":"1262_CR39","doi-asserted-by":"crossref","unstructured":"Lu F, Liang Q, Abi-Mosleh L, Das A, De Brabander JK, Goldstein JL, et al. Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection. eLife. 2015;4:e12177.","DOI":"10.7554\/eLife.12177"},{"key":"1262_CR40","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrendo.2017.91","volume":"13","author":"H Shimano","year":"2017","unstructured":"Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology\u2014divergent pathophysiology. Nat Rev Endocrinol. 2017;13:710\u201330.","journal-title":"Nat Rev Endocrinol."},{"key":"1262_CR41","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","volume":"29","author":"JL Goldstein","year":"2009","unstructured":"Goldstein JL, Brown MS. History of discovery: the LDL receptor. Arterioscler Thromb Vasc Biol. 2009;29:431.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"1262_CR42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13287-019-1342-6","volume":"10","author":"J Caron","year":"2019","unstructured":"Caron J, P\u00e8ne V, Tolosa L, Villaret M, Luce E, Fourrier A, et al. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR\/Cas-mediated genetic correction, and productive hepatitis C virus infection. Stem Cell Res Ther. 2019;10:221.","journal-title":"Stem Cell Res Ther."},{"key":"1262_CR43","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/cvr\/cvy079","volume":"114","author":"Z Ding","year":"2018","unstructured":"Ding Z, Liu S, Wang X, Theus S, Deng X, Fan Y, et al. PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages. Cardiovasc Res. 2018;114:1145\u201353.","journal-title":"Cardiovasc Res."},{"key":"1262_CR44","doi-asserted-by":"crossref","unstructured":"Van Bruggen JAC, Peters F, Cretenet G, Melenhorst JJ, Eldering E, Kater AP. Chronic lymphocytic leukemia actively induces T-cell dysfunction by contact-dependent signaling via CD24 and CD52. Blood. 2021;138:3714.","DOI":"10.1182\/blood-2021-152495"},{"key":"1262_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S1097-2765(02)00591-9","volume":"10","author":"AJ Brown","year":"2002","unstructured":"Brown AJ, Sun L, Feramisco JD, Brown MS, Goldstein JL. Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol Cell. 2002;10:237\u201345.","journal-title":"Mol Cell."},{"key":"1262_CR46","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41589-022-01017-3","volume":"18","author":"SA Lim","year":"2022","unstructured":"Lim SA, Su W, Chapman NM, Chi H. Lipid metabolism in T cell signaling and function. Nat Chem Biol. 2022;18:470\u201381.","journal-title":"Nat Chem Biol."},{"key":"1262_CR47","doi-asserted-by":"crossref","unstructured":"Ghittoni R. Simvastatin inhibits T\u2010cell activation by selectively impairing the function of Ras superfamily GTPases. FASEB J. 2005. [cited 2024]. Available from: https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.04-2702fje.","DOI":"10.1096\/fj.04-2702fje"},{"key":"1262_CR48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cell.2008.04.052","volume":"134","author":"SJ Bensinger","year":"2008","unstructured":"Bensinger SJ, Bradley MN, Joseph SB, Zelcer N, Janssen EM, Hausner MA, et al. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell. 2008;134:97\u2013111.","journal-title":"Cell."},{"key":"1262_CR49","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1039\/C9CC09993J","volume":"56","author":"S Uchinomiya","year":"2020","unstructured":"Uchinomiya S, Matsunaga N, Kamoda K, Kawagoe R, Tsuruta A, Ohdo S, et al. Fluorescence detection of metabolic activity of the fatty acid beta oxidation pathway in living cells. Chem Commun. 2020;56:3023\u20136.","journal-title":"Chem Commun."},{"key":"1262_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/imr.12655","volume":"283","author":"B Raud","year":"2018","unstructured":"Raud B, McGuire PJ, Jones RG, Sparwasser T, Berod L. Fatty acid metabolism in CD8 + T cell memory: challenging current concepts. Immunol Rev. 2018;283:213\u201331.","journal-title":"Immunol Rev."},{"key":"1262_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","volume":"78","author":"SM Houten","year":"2016","unstructured":"Houten SM, Violante S, Ventura FV, Wanders RJA. The biochemistry and physiology of mitochondrial fatty acid \u03b2-oxidation and its genetic disorders. Annu Rev Physiol. 2016;78:23\u201344.","journal-title":"Annu Rev Physiol."},{"key":"1262_CR52","first-page":"e23478","volume":"38","author":"M Schwantje","year":"2024","unstructured":"Schwantje M, Mosegaard S, Knottnerus SJG, van Klinken JB, Wanders RJ, van Lenthe H, et al. Tracer-based lipidomics enables the discovery of disease-specific candidate biomarkers in mitochondrial \u03b2-oxidation disorders. FASEB J Publ Fed Am Soc Exp Biol. 2024;38:e23478.","journal-title":"FASEB J Publ Fed Am Soc Exp Biol."},{"key":"1262_CR53","doi-asserted-by":"crossref","unstructured":"Amaral AU, Wajner M. Recent advances in the pathophysiology of fatty acid oxidation defects: secondary alterations of bioenergetics and mitochondrial calcium homeostasis caused by the accumulating fatty acids. Front Genet. 2020;11. [cited 2025]. Available from: https:\/\/www.frontiersin.org\/journals\/genetics\/articles\/10.3389\/fgene.2020.598976\/full.","DOI":"10.3389\/fgene.2020.598976"},{"key":"1262_CR54","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejphar.2015.03.091","volume":"785","author":"TY Hou","year":"2016","unstructured":"Hou TY, McMurray DN, Chapkin RS. Omega-3 fatty acids, lipid rafts, and T cell signaling. Eur J Pharmacol. 2016;785:2\u20139.","journal-title":"Eur J Pharmacol."},{"key":"1262_CR55","doi-asserted-by":"publisher","first-page":"e02882","DOI":"10.7554\/eLife.02882","volume":"3","author":"A Das","year":"2014","unstructured":"Das A, Brown MS, Anderson DD, Goldstein JL, Radhakrishnan A. Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis. eLife 2014;3:e02882.","journal-title":"eLife"},{"key":"1262_CR56","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.exger.2003.10.031","volume":"39","author":"A Larbi","year":"2004","unstructured":"Larbi A, Douziech N, Khalil A, Dupuis G, Ghera\u00efri S, Gu\u00e9rard KP, et al. Effects of methyl-beta-cyclodextrin on T lymphocytes lipid rafts with aging. Exp Gerontol. 2004;39:551\u20138.","journal-title":"Exp Gerontol."},{"key":"1262_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1074\/jbc.M107474200","volume":"277","author":"M Zubiaur","year":"2002","unstructured":"Zubiaur M, Fern\u00e1ndez O, Ferrero E, Salmer\u00f3n J, Malissen B, Malavasi F, et al. CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt\/protein kinase B and Erk activation in the absence of the CD3-\u03b6 immune receptor tyrosine-based activation motifs *. J Biol Chem. 2002;277:13\u201322.","journal-title":"J Biol Chem."},{"key":"1262_CR58","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1210\/me.2002-0190","volume":"17","author":"T Yoshikawa","year":"2003","unstructured":"Yoshikawa T, Ide T, Shimano H, Yahagi N, Amemiya-Kudo M, Matsuzaka T, et al. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling. Mol Endocrinol. 2003;17:1240\u201354.","journal-title":"Mol Endocrinol."},{"key":"1262_CR59","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.ccell.2023.04.016","volume":"41","author":"C Yan","year":"2023","unstructured":"Yan C, Zheng L, Jiang S, Yang H, Guo J, Jiang LY, et al. Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity. Cancer Cell. 2023;41:1276\u201393.e11.","journal-title":"Cancer Cell."},{"key":"1262_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2891-13-17","volume":"13","author":"B Grygiel-G\u00f3rniak","year":"2014","unstructured":"Grygiel-G\u00f3rniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications\u2014a review. Nutr J. 2014;13:17.","journal-title":"Nutr J."},{"key":"1262_CR61","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/383728a0","volume":"383","author":"BA Janowski","year":"1996","unstructured":"Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signalling pathway mediated by the nuclear receptor LXR\u03b1. Nature. 1996;383:728\u201331.","journal-title":"Nature."},{"key":"1262_CR62","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrm4074","volume":"16","author":"Y Wang","year":"2015","unstructured":"Wang Y, Viscarra J, Kim SJ, Sul HS. Transcriptional regulation of hepatic lipogenesis. Nat Rev Mol Cell Biol. 2015;16:678\u201389.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"1262_CR63","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.tem.2010.01.001","volume":"21","author":"JR Krycer","year":"2010","unstructured":"Krycer JR, Sharpe LJ, Luu W, Brown AJ. The Akt\u2013SREBP nexus: cell signaling meets lipid metabolism. Trends Endocrinol Metab. 2010;21:268\u201376.","journal-title":"Trends Endocrinol Metab."},{"key":"1262_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-022-04730-y","volume":"13","author":"M Tang","year":"2022","unstructured":"Tang M, Dong X, Xiao L, Tan Z, Luo X, Yang L, et al. CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma. Cell Death Dis. 2022;13:1\u201313.","journal-title":"Cell Death Dis."},{"key":"1262_CR65","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41577-023-00838-0","volume":"23","author":"G Di Conza","year":"2023","unstructured":"Di Conza G, Ho PC, Cubillos-Ruiz JR, Huang SCC. Control of immune cell function by the unfolded protein response. Nat Rev Immunol. 2023;23:546\u201362.","journal-title":"Nat Rev Immunol."},{"key":"1262_CR66","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.bbalip.2017.07.009","volume":"1862","author":"C Sztalryd","year":"2017","unstructured":"Sztalryd C, Brasaemle DL. The perilipin family of lipid droplet proteins: Gatekeepers of intracellular lipolysis. Biochim Biophys Acta. 2017;1862:1221\u201332.","journal-title":"Biochim Biophys Acta."},{"key":"1262_CR67","doi-asserted-by":"publisher","first-page":"42664","DOI":"10.1074\/jbc.M112.386045","volume":"287","author":"E Moln\u00e1r","year":"2012","unstructured":"Moln\u00e1r E, Swamy M, Holzer M, Beck-Garc\u00eda K, Worch R, Thiele C, et al. Cholesterol and sphingomyelin drive ligand-independent T-cell antigen receptor nanoclustering*. J Biol Chem. 2012;287:42664\u201374.","journal-title":"J Biol Chem."},{"key":"1262_CR68","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/emboj.2009.6","volume":"28","author":"T Zech","year":"2009","unstructured":"Zech T, Ejsing CS, Gaus K, de Wet B, Shevchenko A, Simons K, et al. Accumulation of raft lipids in T-cell plasma membrane domains engaged in TCR signalling. EMBO J. 2009;28:466\u201376.","journal-title":"EMBO J."},{"key":"1262_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/srep10082","volume":"5","author":"J Dinic","year":"2015","unstructured":"Dinic J, Riehl A, Adler J, Parmryd I. The T cell receptor resides in ordered plasma membrane nanodomains that aggregate upon patching of the receptor. Sci Rep. 2015;5:10082.","journal-title":"Sci Rep."},{"key":"1262_CR70","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s13238-021-00821-2","volume":"12","author":"J Yuan","year":"2021","unstructured":"Yuan J, Cai T, Zheng X, Ren Y, Qi J, Lu X, et al. Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling. Protein Cell. 2021;12:240\u201360.","journal-title":"Protein Cell."},{"key":"1262_CR71","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature17412","volume":"531","author":"W Yang","year":"2016","unstructured":"Yang W, Bai Y, Xiong Y, Zhang J, Chen S, Zheng X, et al. Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism. Nature. 2016;531:651\u20135.","journal-title":"Nature."},{"key":"1262_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52666-y","volume":"15","author":"JA Guerrero","year":"2024","unstructured":"Guerrero JA, Klysz DD, Chen Y, Malipatlolla M, Lone J, Fowler C, et al. GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potency. Nat Commun. 2024;15:8658.","journal-title":"Nat Commun."},{"key":"1262_CR73","doi-asserted-by":"publisher","first-page":"e006522","DOI":"10.1136\/jitc-2022-006522","volume":"11","author":"K Lontos","year":"2023","unstructured":"Lontos K, Wang Y, Joshi SK, Frisch AT, Watson MJ, Kumar A, et al. Metabolic reprogramming via an engineered PGC-1\u03b1 improves human chimeric antigen receptor T-cell therapy against solid tumors. J Immunother Cancer. 2023;11:e006522.","journal-title":"J Immunother Cancer."},{"key":"1262_CR74","doi-asserted-by":"publisher","first-page":"eadn2717","DOI":"10.1126\/sciimmunol.adn2717","volume":"9","author":"A Bevilacqua","year":"2024","unstructured":"Bevilacqua A, Franco F, Lu YT, Rahiman N, Kao KC, Chuang YM, et al. PPAR\u03b2\/\u03b4-orchestrated metabolic reprogramming supports the formation and maintenance of memory CD8+ T cells. Sci Immunol. 2024;9:eadn2717.","journal-title":"Sci Immunol."}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01262-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01262-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01262-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T18:03:16Z","timestamp":1745949796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-025-01262-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":74,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["1262"],"URL":"https:\/\/doi.org\/10.1038\/s41423-025-01262-1","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}